Mobile teledermoscopy for patients at high risk of cutaneous melanoma: A single-arm, feasibility study of a clinical intervention at two tertiary centres (MOBILEMEL)

被引：0
|
作者：
Martin, Arthur [1 ]
Cust, Anne [2 ]
Lo, Serigne [3 ]
Morton, Rachael [4 ]
Kasparian, Nadine [5 ]
Teh, Natalie [6 ]
Collgros, Helena [7 ,8 ]
Martin, Linda [9 ]
Guitera, Pascale [10 ]
机构：
[1] Melanoma Inst Australia, Wollstonecraft, NSW, Australia
[2] Univ Sydney, Melanoma Inst Australia, Joint Venture Canc Council, Daffodil Ctr, Sydney, NSW, Australia
[3] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia
[4] Univ Sydney, Camperdown, NSW, Australia
[5] Univ New South Wales, Sydney, NSW, Australia
[6] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[7] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia
[8] Royal Prince Alfred Hosp, Sydney Melanoma Diagnost Ctr, Sydney, NSW, Australia
[9] Melanoma Inst Australia, Sydney, NSW, Australia
[10] Melanoma Inst Australia, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：82 / 82
页数：1
相关论文
共 50 条
  • [21] Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
    Burger, Jan A.
    Keating, Michael J.
    Wierda, William G.
    Hartmann, Elena
    Hoellenriegel, Julia
    Rosin, Nathalie Y.
    de Weerdt, Iris
    Jeyakumar, Ghayathri
    Ferrajoli, Alessandra
    Cardenas-Turanzas, Marylou
    Lerner, Susan
    Jorgensen, Jeffrey L.
    Nogueras-Gonzalez, Graciela M.
    Zacharian, Gracy
    Huang, Xuelin
    Kantarjian, Hagop
    Garg, Naveen
    Rosenwald, Andreas
    O'Brien, Susan
    LANCET ONCOLOGY, 2014, 15 (10): : 1090 - 1099
  • [22] Feasibility of individualized home exercise programs for patients with head and neck cancer-study protocol and first results of a multicentre single-arm intervention trial (OSHO #94)
    Felser, Sabine
    Rogahn, Julia
    Glass, Anne
    Bonke, Lars Arne
    Strueder, Daniel Fabian
    Stolle, Jana
    Schulze, Susann
    Blaurock, Markus
    Kriesen, Ursula
    Junghanss, Christian
    Grosse-Thie, Christina
    PLOS ONE, 2024, 19 (08):
  • [23] Family-centered online positive psychological intervention for breast cancer patients and family caregivers: a single-arm pre-post study of feasibility and preliminary effects
    Yao Zhang
    Ruijin Tang
    Dan Wang
    Xiaoxu Li
    Liuna Bi
    Ming Shi
    Jing Han
    BMC Psychology, 13 (1)
  • [24] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups
    Zimmer, L.
    Eigentler, T.
    Vaubel, J.
    Mohr, P.
    Jradi, Z.
    Kiecker, F.
    Utikal, J.
    Simon, J. -C.
    Berking, C.
    Kaempgen, E.
    Hauschild, A.
    Dippel, E.
    Rompel, R.
    Fluck, M.
    Stadler, R.
    Herbst, R. A.
    Terheyden, P.
    Loquai, C.
    Garbe, C.
    Schadendorf, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 : 32 - 32
  • [25] A single-arm, phase II clinical study of imatinib mesylate/toripalimab combo in patients (pts) with advanced melanoma harboring c-Kit mutation or amplification
    Si, L.
    Qi, Z.
    Dai, J.
    Bai, X.
    Mao, L.
    Li, C.
    Wei, X.
    Cui, C-L.
    Chi, Z.
    Sheng, X.
    Kong, Y.
    Bixia, T.
    Zhou, L.
    Lian, B.
    Wang, X.
    Duan, R.
    Guo, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S919 - S919
  • [26] Feasibility of an exercise-nutrition-psychology integrated rehabilitation model based on mobile health and virtual reality for cancer patients: a single-center, single-arm, prospective phase II study
    Qi, Yuan
    Wang, Mengjie
    Xue, Ya
    Yue, Jingyan
    Qi, Chunjian
    Shang, Weihu
    Meng, Weifen
    Zhu, Wenyu
    Pu, Xiaolin
    Li, Dongqing
    Jiang, Hua
    BMC PALLIATIVE CARE, 2024, 23 (01):
  • [27] Sequential azacitidine and lenalidomide in patients with high-risk myelodysplastic syndromes and acute myeloid leukaemia: a single-arm, phase 1/2 study
    DiNardo, Courtney D.
    Daver, Naval
    Jabbour, Elias
    Kadia, Tapan
    Borthakur, Gautam
    Konopleva, Marina
    Pemmaraju, Naveen
    Yang, Hui
    Pierce, Sherry
    Wierda, William
    Bueso-Ramos, Carlos
    Patel, Keyur P.
    Cortes, Jorge E.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    LANCET HAEMATOLOGY, 2015, 2 (01): : E12 - E20
  • [28] Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
    Zsiros, Jozsef
    Brugieres, Laurence
    Brock, Penelope
    Roebuck, Derek
    Maibach, Rudolf
    Zimmermann, Arthur
    Childs, Margaret
    Pariente, Daniele
    Laithier, Veronique
    Otte, Jean-Bernard
    Branchereau, Sophie
    Aronson, Daniel
    Rangaswami, Arun
    Ronghe, Milind
    Casanova, Michela
    Sullivan, Michael
    Morland, Bruce
    Czauderna, Piotr
    Perilongo, Giorgio
    LANCET ONCOLOGY, 2013, 14 (09): : 834 - 842
  • [29] Complex lifestyle intervention among inactive older adults with elevated cardiovascular disease risk and obesity: a mixed-method, single-arm feasibility study for RESTART—a randomized controlled trial
    Trygve S. Deraas
    Laila Hopstock
    Andre Henriksen
    Bente Morseth
    Anne Sofie Sand
    Inger Njølstad
    Sigurd Pedersen
    Edvard Sagelv
    Jonas Johansson
    Sameline Grimsgaard
    Pilot and Feasibility Studies, 7
  • [30] Open-label, multicenter, single-arm phase II study (DeCOG-Trial) to further evaluate the efficacy and safety of ipilimumab in patients with cutaneous melanoma and rare subgroups.
    Zimmer, Lisa
    Eigentler, Thomas K.
    Vaubel, Julia-Marianne
    Mohr, Peter
    Jradi, Zeinab
    Kiecker, Felix
    Utikal, Jochen
    Berking, Carola
    Kaempgen, Eckhart
    Hauschild, Axel
    Dippel, Edgar
    Rompel, Rainer
    Fluck, Michael
    Stadler, Rudolf
    Herbst, Rudolf
    Terheyden, Patrick
    Garbe, Claus
    Loquai, Carmen
    Schadendorf, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345